| Application no. and date | 17770846.8 (espacenet) (Federated) (European Patent Register), 20170316 | | Patent/reg. no. and date | DK/EP 3432872, 20210825 | | Publication date | 20190130 | | Priority no. and date | US 201662312623 P, 20160324 | | EP pub. no. and date |
EP 3432872 20190130 | | Effective date | | | Applicant/owner | Orbus Therapeutics, Inc., 2475 East Bayshore Road
Suite 105
Palo Alto, CA 94303, US | | Applicant ref. no. | P77550DK01 | | Inventor | LEVIN, Victor, A., 2475 East Bayshore Road
Suite 105
Palo Alto, CA 94303, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/195 (2006.01) , A61K 31/197 (2006.01) , A61P 35/04 (2006.01) | | Title | EFLORNITHIN TIL ANVENDELSE TIL BEHANDLING AF TEMOZOLOMID TILBAGEVENDENDE/REFRAKTÆR ANAPLASTISK ASTROCYTOM | | Int. application no. | US2017022718 | | Int. publication no. | WO2017165187 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
